Blog from IFPMA ADG Greg Perry following his visit to Cabo Verde
Find out here an insight that Greg Perry gives around WHO Afro Global Health Forum 2019
Read More
Thought Leader Series in Vaccines
A mustread from experts talking about the value of vaccines
Read More
Our response to Zika virus
Check here about the R&D blueprint against Zika
Read More
Women’s Cancer Initiative in the Americas
Partnership to improve prevention of women’s cancers and quality of cancer registries in LAC reaches 1 year milestone
Read More
Latest News
2020-09-21 12:00:07
Innovative vaccine and medicine industry applaud country commitments to COVAX Facility
Vaccine makers, and biopharmaceutical industry more generally, are encouraged to see the broad international support the COVAX Facility has received ...
Read More2020-09-03 09:29:26
Biopharma industry updates on COVID-19 treatments progress and warns about upholding regulatory standards of quality
Geneva, 3 September 2020 – Seven months into the pandemic, the innovative biopharmaceutical industry continues ...
Read More2020-07-26 18:16:22
WADA and IFPMA strengthen collaboration in the protection of clean sport
Geneva / Montreal, 28 July 2020: The World Anti-Doping Agency (WADA) and the International Federation ...
Read More2020-07-09 13:30:55
New AMR Action Fund steps in to save collapsing antibiotic pipeline with pharmaceutical industry investment of US$1 billion
New AMR Action Fund steps in to save collapsing antibiotic pipeline with pharmaceutical industry investment ...
Read More2020-06-08 07:54:23
Global Pharma Body Names New Communications Director
Geneva, 8 June, 2020: The industry body representing research-based biopharmaceutical companies and regional and national ...
Read More2020-06-04 13:02:10
Pharma pledges to continue 20 year partnership with Gavi, the Vaccine Alliance
IFPMA members have worked for 20 years with Gavi to stem the ravages of childhood ...
Read More2020-05-28 15:00:58
Pharma partners in efforts to give coronavirus vaccine for everyone
Geneva, 28 May 2020. IFPMA has today updated the world’s media on the biopharmaceutical industry’s ...
Read More
Latest Statement
2020-09-22 15:30:19
Innovative health industries united in welcoming UNGA Resolution on “Comprehensive and Coordinated Response to the COVID-19 Pandemic”
Joint Statement – Global Innovative Health Industries Alliance Published on September 22nd, 2020 Innovative health industries united in welcoming United ...
Read More2020-09-17 13:00:35
IFPMA Statement on the G-FINDER Report “Landscape of Emerging Infectious Disease R&D: Preventing the Next Pandemic”
Geneva, 28 May 2020. IFPMA has today updated the world’s ...
Read More2020-09-17 07:00:41
IFPMA Statement to G20 Health and Finance Ministers
Geneva, 28 May 2020. IFPMA has today updated the world’s ...
Read More2020-09-15 14:55:09
Safety of vaccinated individuals is the top priority in development of COVID-19 vaccines
Geneva, 28 May 2020. IFPMA has today updated the world’s ...
Read More2020-09-08 11:44:42
COVID-19 Vaccine Maker Pledge
Geneva, 28 May 2020. IFPMA has today updated the world’s ...
Read More2020-08-27 15:26:10
Innovative vaccine industry strongly committed to rigorous regulatory standards for approval of COVID-19 vaccines
Geneva, 28 May 2020. IFPMA has today updated the world’s ...
Read More2020-08-18 09:41:07
WHO AFRO 70th REGIONAL MEETING Agenda item: 6 “Special event on the COVID-19 response in the WHO African Region”
Geneva, 28 May 2020. IFPMA has today updated the world’s ...
Read More
mailto:s.kaenzig@ifpma.org +41 22 338 32 49
direct line
Twitter skaenzig
Sadia Kaenzig - Communications Manager
Sadia manages communications on issues including regulatory, intellectual property protection, trade and the economic footprint of the research-based pharmaceutical industry, research and development ecosystem and innovation, vaccines including influenza vaccines, and biotherapeutics.
mailto:m.depol@ifpma.org +41 22 338 32 20
direct line
Twitter @MorganePol
Morgane De Pol - Communications and Public Affairs
Morgane manages communications on issues including the research-based pharmaceutical industry’s commitment to achieving sustainable and inclusive development, advancing Universal Health Coverage, designing transformational partnerships to build healthier societies, boosting innovation for neglected tropical diseases, expanding access to high quality treatments for infectious and chronic diseases, fighting counterfeit medicines, and promoting resilient and efficient health systems.
Our Brouchure
2015 Edition
A shared commitment to global health
At IFPMA we advocate policies and practices that encourage the discovery of and access to life-saving and life-enhancing medicines and vaccines, for people everywhere.
Our Logo
Full colour EPS format
Our Logo
Full colour PNG format
FULL Name LOGO
Full colour EPS format
FULL Name LOGO
Full colour PNG format
Hot Topic
Pharmacovigilance: Do your bit, play your part!
Pharmacovigilance is one of the key steps to ensuring the safety of all our medicines, including biotherapeutics and vaccines. It encourages an ongoing cycle of communication between patients, health professionals, regulatory authorities, and our biopharma industry which is
Read MoreInterview
IFPMA 2015 interview series 'Biodiversity, human health, and pharma'
A must-watch: Dr Manisha A. Desai, assistant general patent counsel at Eli Lilly and Company, gives her take on the importance of the Convention of Biodiversity and the Nagoya Protocol for the pharma industry. What's key is to
Read MoreOur Blog
Interview – BBC World Service Marketplace Morning Report - Vials, syringes, packaging: The small but vital components of COVID-19 vaccine distribution
Thomas Cueni, IFPMA Director General, spoke to BBC World Service Marketplace Morning Report about the efforts and challenges to produce and deliver a vaccine for COVID-19 Victoria Craig One of the keys to getting economies back to some form of normalcy is a vaccine. The US said that it could begin delivering one within 24 hours of FDA approval. But what about the rest of...
Read More
Interview - Asahi TV Japan - Solidarity at the core of COVAX Facility
Interview - Asahi TV Japan - Solidarity at the core of COVAX Facility Thomas Cueni, IFPMA Director General, spoke to Asahi TV in Japan on 18 September 2020 about COVAX and the importance of working together in order to guarantee a safe and effective vaccine in both richer and poorer countries. Here are top 5 points discussed (edited for clarity). What are the merits...
Read More
Interview - BBC World Business Report - Will a coronavirus vaccine reach the developing world?
The biopharmaceutical industry has made addressing the pandemic its top priority, devoting its resources, expertise, know-how, and intellectual assets to developing potential treatments and vaccines at record speed, while committing to and engaging in unprecedented levels of international collaboration and coordination through initiatives such as ACT-A, ACTIV and CEPI to ensure equitable access to products being developed. Thomas Cueni, Director General of the International Federation of Pharmaceutical Manufacturers and Associations, had the...
Read MoreLatest Tweets
